| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $296.3M | +50.0% |
| SG&A Expense | $95.9M | +55.9% |
| Operating Income | -$392.2M | -51.4% |
| Interest Expense | $118K | -95.1% |
| Pre-tax Income | -$258.0M | -35.2% |
| Income Tax | $92K | +100.9% |
| Net Income | -$258.0M | -43.1% |
| EPS (Basic) | -$0.44 | +27.9% |
| EPS (Diluted) | -$0.44 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $146.1M | -84.7% |
| Short-term Investments | $910.7M | +165.3% |
| Current Assets | $1.08B | -17.8% |
| Total Assets | $1.29B | -13.1% |
| Current Liabilities | $30.2M | +118.1% |
| Total Liabilities | $128.2M | -25.3% |
| Stockholders' Equity | $1.16B | -11.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$235.9M | -20.5% |
| Capital Expenditures | $54.9M | +69.7% |
| Investing Cash Flow | -$630.8M | -3266.7% |
| Financing Cash Flow | $60.5M | -94.5% |
| Free Cash Flow | -$290.8M | -27.5% |
| +27.9% |